MAGE-5 (5-12)

MAGE-5 (5-12) is a synthetic peptide fragment derived from the melanoma-associated antigen gene family, specifically representing amino acids 5 through 12 of the MAGE-5 protein sequence. As a short, defined peptide, it serves as a valuable tool in immunological and cancer biology research, particularly for studies investigating antigen presentation and T-cell recognition mechanisms. Its sequence specificity and biochemical properties enable its use in probing immune responses, mapping epitope regions, and supporting the development of peptide-based assays. The functional relevance of this peptide fragment lies in its role as a model antigenic determinant, facilitating precise analysis of MAGE-5-related immunogenicity and molecular interactions within experimental systems.

Epitope Mapping: MAGE-5 (5-12) is widely utilized in epitope mapping studies to identify and characterize the minimal antigenic determinants recognized by immune cells. By providing a defined peptide sequence corresponding to a specific region of the MAGE-5 protein, researchers can dissect the fine specificity of antibody or T-cell receptor interactions. This approach is essential for elucidating the molecular basis of antigen recognition, which informs the design of immunodiagnostic reagents and supports fundamental research into tumor antigenicity.

T-Cell Activation Assays: As a well-characterized peptide epitope, MAGE-5 (5-12) is frequently employed in functional assays designed to evaluate T-cell activation, cytokine release, and proliferation responses. When presented by appropriate major histocompatibility complex (MHC) molecules, this peptide can stimulate antigen-specific T cells in vitro, providing a controlled system to assess cellular immune responses. Such assays are instrumental in validating immune recognition pathways and in screening for T-cell reactivity to MAGE family antigens.

Peptide-Based ELISA Development: The defined sequence and immunogenic potential of MAGE-5 (5-12) make it a suitable candidate for use in peptide-based enzyme-linked immunosorbent assays (ELISAs). Incorporating this peptide into assay platforms allows for the detection and quantification of specific antibodies or T-cell responses in biological samples. This application supports serological studies and facilitates the monitoring of immune responses in preclinical research settings, contributing to the assessment of antigen exposure or immunization efficacy.

Synthetic Peptide Reference Standard: In analytical and quality control laboratories, MAGE-5 (5-12) serves as a reference standard for peptide quantification, assay calibration, and validation of analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry. Its well-defined structure and physicochemical properties enable consistent benchmarking of peptide synthesis, purification processes, and detection techniques, ensuring reproducibility and reliability in experimental workflows.

Antigen Processing and Presentation Research: The MAGE-5 (5-12) peptide provides a tractable model for investigating the mechanisms of antigen processing and presentation by professional antigen-presenting cells. By examining how this peptide is loaded onto MHC molecules and presented to T cells, researchers gain insights into the molecular determinants that govern immune recognition of tumor-associated antigens. These studies are foundational for advancing understanding of immune surveillance and for informing strategies in immunotherapy research and antigen design.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics